期刊文献+

Natural product-based treatment potential for type 2 diabetes mellitus and cardiovascular disease

下载PDF
导出
摘要 BACKGROUND Type 2 diabetes(T2D)is a metabolic disease of impaired glucose utilization and a major cause of cardiovascular disease(CVD).The pathogenesis of both diseases shares common risk factors and mechanisms,and both are significant contributors to global morbidity and mortality.Supplements of natural products for T2D mellitus(T2DM)and CVD can be seen as a potential preventive and effective therapeutic strategy.AIM To critically evaluate the therapeutic potential of natural products in T2D and coronary artery disease(CAD).METHODS By using specific keywords,we strategically searched the PubMed database.Randomized controlled trials(RCTs)were searched as the primary focus that examined the effect of natural products on glycemic control,oxidative stress,and antioxidant levels.We focused on outcomes such as low blood glucose levels,adjustment on markers of oxidative stress and antioxidants.After screening fulllength papers,we included 9 RCTs in our review that met our inclusion criteria.RESULTS In the literature search on the database,we found that various natural products like plant secondary metabolites play a diverse role in the management of CAD.American ginseng,sesame oil and cocoa flavanols proved effective in lowering blood glucose levels and controlling blood pressure,which are key factors in managing T2DM and CVD.In diabetic patients Melissa officinalis effectively reduce inflammation and shows diabetes prevention.Both fish oil and flaxseed oil reduced insulin levels and inflammatory markers,suggesting benefits for both conditions.The lipid profile and endothelial function were enhanced by Nigella sativa oil and Terminalia chebula,which is significant for the management of cardiovascular risk factors in T2DM.Additionally Bilberry extract also showed promise for improving glycemic control in patients with T2DM.CONCLUSION The high level of antioxidant,anti-inflammatory,and anti-angiogenic properties found in natural products makes them promising therapeutic options for the management of CAD,with the potential benefit of lowering the risk of CAD.
出处 《World Journal of Diabetes》 SCIE 2024年第7期1603-1614,共12页 世界糖尿病杂志(英文版)(电子版)
  • 相关文献

参考文献2

二级参考文献21

  • 1Xinli Zhang,Chen Chen.A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy[J]. Endocrine . 2012 (3)
  • 2Alessandra Dei Cas,Sadiya S. Khan,Javed Butler,Robert J. Mentz,Robert O. Bonow,Angelo Avogaro,Diethelm Tschoepe,Wolfram Doehner,Stephen J. Greene,Michele Senni,Mihai Gheorghiade,Gregg C. Fonarow.Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure[J]. JACC: Heart Failure . 2014
  • 3Lawrence R. Krakoff,Robert L. Gillespie,Keith C. Ferdinand,Icilma V. Fergus,Ola Akinboboye,Kim A. Williams,Mary Norine Walsh,C. Noel Bairey Merz,Carl J. Pepine.2014 Hypertension Recommendations From the Eighth Joint National Committee Panel Members Raise Concerns for Elderly Black and Female Populations[J]. Journal of the American College of Cardiology . 2014 (4)
  • 4Haleh Ashraf,Mohammad Ali Boroumand,Alireza Amirzadegan,Shaghayegh Ashraf Talesh,Gholamreza Davoodi.Hemoglobin A1C in non-diabetic patients: An independent predictor of coronary artery disease and its severity[J]. Diabetes Research and Clinical Practice . 2013 (3)
  • 5Alessandra Saldanha de Mattos Matheus,Lucianne Righeti Monteiro Tannus,Roberta Arnoldi Cobas,Catia C. Sousa Palma,Carlos Antonio Negrato,Marilia de Brito Gomes,Mario Fritsch Neves.Impact of Diabetes on Cardiovascular Disease: An Update[J]. International Journal of Hypertension . 2013
  • 6Ravi V. Shah,Allison B. Goldfine.Statins and Risk of New-Onset Diabetes Mellitus[J]. Circulation . 2012 (18)
  • 7Arnold C.T. Ng,Victoria Delgado,Matteo Bertini,Rutger W. van der Meer,Luuk J. Rijzewijk,See Hooi Ewe,Hans-Marc Siebelink,Johannes W.A. Smit,Michaela Diamant,Johannes A. Romijn,Albert de Roos,Dominic Y. Leung,Hildo J. Lamb,Jeroen J. Bax.Myocardial Steatosis and Biventricular Strain and Strain Rate Imaging in Patients With Type 2 Diabetes Mellitus[J]. Circulation . 2010 (24)
  • 8Matthew C. Riddle.Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial[J]. Circulation . 2010 (8)
  • 9Laura Ernande,Ernst R. Rietzschel,Cyrille Bergerot,Marc L. De Buyzere,Frédéric Schnell,Laure Groisne,Michel Ovize,Pierre Croisille,Philippe Moulin,Thierry C. Gillebert,Geneviève Derumeaux.Impaired Myocardial Radial Function in Asymptomatic Patients with Type 2 Diabetes Mellitus: A Speckle-Tracking Imaging Study[J]. Journal of the American Society of Echocardiography . 2010 (12)
  • 10A.A. Rivellese,G. Riccardi,O. Vaccaro.Cardiovascular risk in women with diabetes[J]. Nutrition, Metabolism and Cardiovascular Diseases . 2010 (6)

共引文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部